Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Acute transverse myelitis (ATM) associated with COVID 19 infection and vaccination, A case report and literature review.

Author:Medavarapu, Srinivas   Anziska, Yaacov   

Session Name:P10: Autoimmune Neurology: Inflammatory Neuropathy / Inflammatory Myopathy / Neuroimmunology / Clinical Care  

Topic:Autoimmune Neurology  

Program Number:P10.022  

Author Institution:SUNY Downstate Health Sciences University, Brooklyn, NY  

Implementation of a Point of Care MRI Program to Improve Hospital Outcomes in the Inpatient Neurology Setting

Author:Medina, Christopher   Knopp, Edmond   Wen, Aimin   Willie, Christopher   Wright, Paul   

Session Name:S49: General Neurology  

Topic:General Neurology  

Program Number:S49.002  

Author Institution:Nuvance Health, Poughkeepsie, NY  HyperFine, Guilford, CT  Nuvance Health, Poughkeepsie , NY  

Guillain-Barré Syndrome Following Primary Cytomegalovirus Infection in a Patient with Liver Transplantation: a Case Report

Author:Toro, Jaime   Gaitan Alfonso, Jairo   Medina, Thomas   Reyes, Saul   

Session Name:P10: Autoimmune Neurology: Inflammatory Neuropathy / Inflammatory Myopathy / Neuroimmunology / Clinical Care  

Topic:Autoimmune Neurology  

Program Number:P10.002  

Author Institution:Fundación Santa Fe de Bogotá , Bogota, Colombia  Fundación Santa Fe de Bogotá, Bogota, Colombia  

Meningitis Masquerading as Migraine

Author:Ganapathy, Muthu Kuzhali   Medrea, Ioana   

Session Name:P9: Infectious Disease: Spirochetes 1  

Topic:Infectious Disease  

Program Number:P9.007  

Author Institution:SUNY Upstate Medical University, Syracuse, NY  

Long-Term Follow-Up of Onasemnogene Abeparvovec Gene Therapy in Patients with Spinal Muscular Atrophy Type 1

Author:Mendell, Jerry   Wigderson, Melissa   Alecu, Iulian   Yang, Lina   Mehl, Lesa   Connolly, Anne   

Session Name:P7: Child Neurology and Developmental Neurology: Spinomuscular Atrophy/Muscular Dystrophies  

Topic:Child Neurology and Developmental Neurology  

Program Number:P7.006  

Author Institution:Center for Gene Therapy, Nationwide Children’s Hospital, Columbus, OH  Novartis Gene Therapies, Inc., Bannockburn, IL  Novartis Pharmaceuticals, Basel, Switzerland  Novartis Gene Therapies, Inc., East Hanover, NJ  Novartis Institutes for BioMedical Research, Cambridge, MA  Nationwide Children's Hospital, Columbus, OH